Document Detail


Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
MedLine Citation:
PMID:  16679095     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Alcohol septal ablation (ASA) causes remodeling of the upper septum and left ventricular outflow tract (LVOT) and reduction in the LVOT gradient. The time course of gradient reduction early after ASA has not been established. This study characterized the time course of gradient response early after ASA. Patients underwent clinical assessment and transthoracic echocardiography at baseline and immediately, 3 days, 3 months, and 1 year after ASA. Forty-seven patients underwent ASA. The baseline LVOT gradient was 98 +/- 48 mm Hg. Three-month echocardiographic success, defined as > or = 50% gradient reduction from baseline, was achieved in 41 procedures (87%); thus, there were 6 failures. On the basis of percentage reduction in LVOT gradient at 3 days, 2 distinct subgroups of the success group were identified. These were monophasic success (> or = 50% gradient reduction at 3 days and 3 months, n = 25) and triphasic success (< 50% gradient reduction at 3 days but > or = 50% gradient reduction at 3 months, n = 16). LVOT gradient in the triphasic success group was similar to that in the failure group at 3 days (81 +/- 28 vs 99 +/- 31 mm Hg, p = NS) but similar to that of the monophasic success group at 3 months (24 +/- 20 vs 12 +/- 16 mm Hg, p = NS) and at 1 year (27 +/- 24 vs 13 +/- 20 mm Hg, p = NS). In conclusion, many patients who undergo ultimately successful ASA demonstrate triphasic LVOT gradient response patterns, with a large gradient 3 days after the procedure.
Authors:
Danita M Yoerger; Michael H Picard; Igor F Palacios; Gus J Vlahakes; Patricia A Lowry; Michael A Fifer
Related Documents :
18390985 - Dual-chamber defibrillators reduce clinically significant adverse events compared with ...
20485235 - Contrast transesophageal echocardiography using the acunav ultrasound catheter through ...
10758975 - Reinterventions after repair of common arterial trunk in neonates and young infants.
18159105 - Long-term outcome of isolated congenital complete atrioventricular block pacing since n...
10901735 - Scleromyxedema: response to high-dose intravenous immunoglobulin (hdivig).
2634775 - Narcolepsy in a long-haired dachshund.
Publication Detail:
Type:  Journal Article     Date:  2006-03-31
Journal Detail:
Title:  The American journal of cardiology     Volume:  97     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-05-08     Completed Date:  2006-06-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1511-4     Citation Subset:  AIM; IM    
Affiliation:
Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. dyoerger@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Cardiomyopathy, Hypertrophic / physiopathology,  therapy*,  ultrasonography
Echocardiography
Ethanol / therapeutic use*
Female
Heart Septum* / drug effects,  pathology,  ultrasonography
Humans
Male
Middle Aged
Pressure
Sclerosing Solutions / therapeutic use*
Sclerotherapy / methods*
Statistics, Nonparametric
Treatment Outcome
Chemical
Reg. No./Substance:
0/Sclerosing Solutions; 64-17-5/Ethanol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predictive value of noninvasive coronary angiography with multidetector computed tomography to detec...
Next Document:  Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabr...